Jaimy Lee
2020-01-21
business
Novavax shares jump 60% in premarket trading
Shares of Novavax Inc. NVAX, +9.88% rallied 60% in premarket trading on Tuesday on heavy volume. The biotechnology company is developing vaccines, such as NanoFlu, its experimental season flu vaccine that is in late-stage clinical trials. Novavax said last week that it had received a fast-track designation from the Food and Drug Administration, an announcement that pushed up shares by 20% . Investors are paying close attention to the spread of a new coronavirus in Wuhan City, China. The company's stock is down 86% over the last 52 weeks, while the S&P 500 SPX, -1.19% has gained 26%.
